Dublin, April 17, 2017 -- Research and Markets has announced the addition of the "Brain Monitoring Devices Global Market - Forecast to 2023" report to their offering.
The brain monitoring devices global market is expected to grow at mid single digit CAGR to reach $10,011.5 million by 2023. Brain monitoring devices market is mainly classified into products, application and end-users.
The product classification consists of electroencephalography (EEG) devices, magnetoencephalography (MEG) devices, transcranial Doppler sonography (TCD) devices, intracranial pressure (ICP) monitors, cerebral oximeters, magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, sleep monitoring devices and accessories.
The electroencephalography devices market is further segmented into by product type which includes 8-channel, 21-channel, 25-channel, 32-channel, 40-channel and multi-channel and by modality includes standalone/fixed EEG devices and portable EEG devices. The magnetic resonance imaging is divided based upon technology into low and middle field MRI, high field MRI and very high field MRI. Finally computed tomography devices is further classified into low slice CT, medium slice CT and high slice CT depending on the technology.
The global brain monitoring devices market by application is segmented into neurodegenerative disorders, brain tumor, sleep disorders, psychiatric behavioural disorders and other applications. The neurodegenerative disorders is sub segmented into epilepsy, Parkinson's disease, Huntington's disease, stroke, traumatic brain injury (TBI) and dementia whereas sleep disorders is sub classified into sleep apnea, insomnia, hypersomnia and sleep movement disorders. Psychiatric behavioural disorders are sub divided into autism, schizophrenia, dyslexia, bipolar disorders and depression. Other application is sub segmented into surgery, headache disorders, anesthesia and hydrocephalus.
The end-users of brain monitoring devices market are hospitals, home care, ambulatory surgical centers and clinics, diagnostic centers and other end users.
While increasing focus on minimally invasive brain monitoring procedure and extended application of devices in clinical trials are some of the opportunities that are propelling the growth of the market. However shortage of trained professionals, high cost of complex devices, unfavourable reimbursement policies, stringent regulatory guidelines and competition from local players in emerging markets are hampering the growth of the market.
Factors Influencing Market
Drivers and Opportunities
- Growing Incidence and Prevalence of Neurological Disorders
- Rising Awareness About Neurodegenerative Disorders
- Growing Healthcare Spending
- Technological Advancements/Innovations Offering Wider Scope of Applications for Brain Monitoring
- Increasing Focus on Minimally Invasive Brain Activity Monitoring Procedures
- Extended Application of Devices in Clinical Trials
Restraints & Threats
- High Cost of Complex Devices
- Lack of Skilled Neurologists
- Stringent Regulations and Legislations Guiding the Brain Monitoring Device Manufacturers
- Unfavorable Reimbursement Policies
Porter's Five Force Analysis
Regulatory Guidelines
- United States
- Europe
- Japan
- India
- China
Reimbursement Scenario
Patent Trends
Supply Chain Analysis
Brain Monitoring Devices Number of Units
Brain Monitoring Devices Under Clinical Trial
Recent Techniques Based-On Application
Market Share Analysis by Major Players
Individual Brain Monitoring Devices Market Share Analysis by Major Players
Technological Advancement
- Dissolvable Brain Implants
- Diffused Optical Tomography (DOT)
- EAR Electroencephalography (EAR-EEG)
- Portable EEG Devices
- Brain Tissue Oxygen Tension Monitors
- Wireless Helmet
Companies Mentioned
- AD Instruments
- AdTech Medical Instrument Corporation
- Advanced Brain Monitoring Inc
- Alltech Medical Systems
- ANT Neuro
- Atys Medical
- Avertus Inc
- Avonix Imaging
- B.M. Tech Worldwide Co. Ltd
- Beddit
- Biopac
- Brain Products GmbH
- BrainScope Inc
- Braintronics B.V.
- Cadwell Laboratories
- CAS Medicals Inc
- Cerebrotech Medical Systems
- CleveMed Medical Devices Inc
- Codman & Shurtleff
- Cognionics Inc
- Compumedics Limited
- Context Vision
- CTF MEG International services
- Dantec Medical
- EB Neuro SpA
- Electrical Geodesics Incorporated
- Elekta AB
- Elminda limited
- Emotiv Inc
- Entertech
- FISO Technologies Inc
- Fitbit
- Gaeltec Devices Limited
- GE Healthcare
- GlaxoSmithKline
- HeadSense Medical Inc
- Heinen + Löwenstein GmbH & Co. KG
- Hello Inc
- Hitachi Limited
- Imec
- Infrascan Inc
- InSightec
- Integra Lifesciences
- Jawbone
- Johnson & Johnson
- Koninklijke Philips N.V.
- Koven Technology Canada Inc
- Magnetica
- Masimo Corporation
- MedTech
- Medtronic
- MicroMed Spa
- Misfit
- Mitsar Co. Ltd
- Moberg Research
- MR solutions
- Natus Medical Inc
- NeMoDevices AG
- Neural Analytics Inc
- NeuroCare Group GmbH
- Neuroelectrics Company
- NeuroPace Inc
- Neurosky
- Neurostyle
- Neurovigil
- NeuroWave Systems Inc
- Neusoft Medical Systems Co. Ltd
- Nihon Kohden Corporation
- Nonin Medical Inc
- Nox Medical
- Ornim Inc
- Orsan Medical Technologies Ltd
- Raumedic AG
- Recorders & Medicare Systems Pvt Ltd
- Resmed
- Rhythm
- Ricoh
- Rimed Limited
- Rythm
- Shenzhen Delica Medical Equipment Co. Ltd
- Siemens Healthineers
- Somnomedics GmbH
- Sophyra
- Spencer Technologies
- Spiegelberg GmbH
- SyntheticMR
- Third Eye Diagnostic Inc
- Toshiba
- Tristan Technologies Inc
- Varian Medical Systems
- Vittamed Corporation
- Weinmann Medical Technology
- Wide Med Technologies Ltd
- Withings
For more information about this report visit http://www.researchandmarkets.com/research/5h7rls/brain_monitoring
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Neurology Devices


Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



